Analyzing current trends and future directions in I-O clinical development - Podcast

Published: 8 October 2020
Daina Graybosch
Daina Graybosch
Managing Director, Immuno-Oncology, SVB Leerink

Daina Graybosch is a Senior Research Analyst at SVB Leerink covering Immuno-Oncology. Prior to joining the firm in 2018, Dr Graybosch worked at McKinsey & Company as a Senior Expert and Head of Mckinsey’s Center for Asset Optimization, as well as the US Head of the McKinsey Cancer Center. In these roles, Dr Graybosch developed several McKinsey solutions that bring data and advanced analytics to pharmaceutical development decisions. In her 11 years at McKinsey, Dr Graybosch developed a rich understanding of oncology through her work with companies across the value chain, including Pharmaceutical, Diagnostic, Academic Medical Center, and Genomic/Data. Dr Graybosch earned a PhD in Chemistry and Chemical Biology from Harvard University and dual BS degrees in Biology and Chemistry from the University of Utah.

Read now